- Procter & Gamble Co PG reported fourth-quarter FY21 sales growth of 7.1% year-on-year, to $18.95 billion, beating the analyst consensus of $18.36 billion.
- Organic sales increased 4%, driven by a 1% increase in shipment volume, a 1% increase in pricing, and a favorable mix impact of 1%.
- Sales in the beauty segment rose 11%, the Grooming segment expanded 10%, and Health Care jumped 18%.
- Gross profit increased 5% Y/Y to $9.2 billion. The reported gross margin decreased by 120 basis points.
- The operating margin contracted 100 basis points to 18.7%, while operating income for the quarter rose 2% to $3.5 billion.
- PG Generated an operating cash flow of $4.1 billion for Q2 and held $10.3 billion in cash and equivalents as of June 30, 2021.
- Adjusted EPS of $1.13 beat the analyst consensus of $1.09.
- "As we look forward to fiscal 2022, we expect to continue to grow top-line and bottom-line and to deliver another year of strong cash return to shareholders despite a challenging cost and operating environment," said CEO David Taylor.
- Outlook: P&G expects FY22 all-in sales growth and organic sales growth of 2% - 4%.
- The company expects GAAP EPS growth of 6% - 9%. Core EPS growth of 3% - 6% from $5.66 in FY21, versus the consensus of $5.93.
- P&G also expects to pay over $8 billion in dividends and repurchase $7 billion - $9 billion of common shares in FY22.
- PG CFO told Reuters that input costs across the range are high, with pulp, resin, and polypropylene being the primary drivers.
- Price action: PG shares are trading higher by 1.31% at $141.31 in premarket on the last check Friday.
- Photo by WikimediaImages from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
